TABLE 5.

Fixing patient’s age, the marginal effects of chief physician compared with the deputy chief physician on biosimilar uptake.

Patient’s age	dy/dx	95%CI	p-value
25	.17	.05–.28	.01
30	.18	.07–.28	<.01
35	.19	.10–.28	<.01
40	.19	.12–.27	<.01
45	.20	.13–.27	<.01
50	.19	.12–.26	<.01
55	.17	.09–.25	<.01
60	.13	.02–.25	.03
65	.07	−.12–.26	.49
70	−.02	−.32–.27	.89